Censoring occurs when the failure times of some individuals within the observation sample cannot be observed. Censoring is often unavoidable in time-to-event studies. A patient in a clinical trial may ...
Individual participant data (IPD) from oncology clinical trials is invaluable for identifying factors that influence trial success and failure, improving trial design and interpretation, and comparing ...
Stakeholders ask for flexibility, more examples in FDA guidance on overall survival in cancer trials
Stakeholders asked the US Food and Drug Administration for more examples in comments on a recently issued guidance on the use of overall survival as an endpoint in oncology drug clinical trials. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results